Fang PDFs Flashcards

1
Q

What metric is used to define the rate of absorption?

A

Cmax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Comparing a drug product’s oral area under the curve (AUCo) to its own IV area under the curve (AUCiv) is an estimate of what?

A

Absolute Bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Comparing the Plasma Concentration vs. Time profile of a Test Product to its comparator Reference Product is an estimate of what?

A

Relative Bioavailability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What type of test volunteers should be used when conducting Comparative Bioavailability Studies?

A

Normal & Healthy Patients (as conclusions drawn from the study should hold true in populations).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How would we define ‘bioequivalence’?

A

Test Product is expected to have the same therapeutic effect & safety profile as its Reference Product.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a ‘Two Period Crossover’ study, and what benefit does it have over other study types?

A

-Same subject gets Test Product, then gets Reference Product at a different time.

-Intra-subject error is lower (in comparison to Inter-subject Error if we used more than one subject to compare the two products).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is a ‘Replicated Crossover’ study? What pros & cons does it have compared to other study types?

A

-Each formulation (ie. Test & Reference Product) examined more than once in a patient.

-Less subjects required (good) but more patient appearances needed (bad).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What types of patients would it be suitable to conduct a ‘Crossover Without Washout’ type study?

A

For those whom abrupt drug discontinuation would be unethical or unsafe to do.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What types of drug products would it be advisable to conduct a ‘Parallel’ study type?

A

1) Long t1/2elim
2) Drug w depot effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What four study factors influence how many subjects should be used?

A

1) Standard

2) Mean Difference (btw Test & Reference Formulations)

3) Intra-Subject Variance

4) Study Power

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the bare minimum number of test subjects that should be used in Comparative Bioequivalency Studies?

A

12

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

In bioequivalence studies with more than twenty subjects, what percentage of patients can be excluded due to being considered “statistical outliers”?

A

No more than 5%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

In bioequivalence studies with less than twenty subjects, what number of patients can be excluded due to being considered “statistical outliers”?

A

1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What two PK parameters are typically examined in the determination of statistical outliers?

A

AUC & Cmax

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

When conducting bioequivalence studies in the “Fasted State”, how long must subjects go without food? Water?

A

Food: 8hrs before drug administration (but no closer than that).

Water: Up to 1hr before drug administration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

In “Fasted” bioequivalence studies, after how many hours post-administration of drug are subjects okay to eat?

A

4hrs (so long as meals are standardized across patient groups).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How would water intake timelines differ in a “Fasted” study if the formulation of the product was an ODT (instead of a traditional IR oral tablet)?

A

IR: Water up to 1hr before drug admin, can drink water right after!

ODT: Water up to 1hr before drug admin, no water for 1hr after dose given!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

If conducting a “Fed State” bioequivalence study, when should a meal be given?

A

30mins prior to drug administration

18
Q

When giving a meal for a “Fed State” bioequivalence study, what kcal target should one aim for? What percentage of it should be derived from fats?

A

800 - 1000kcal ; 50% from fats.

19
Q

Drug concentration sampling should last at least ___x the terminal half-life of the drug being examined.

A

3x

20
Q

A bare minimum of ____ drug concentration samples per subject per dose should be taken.

A

12

21
Q

What bodily fluid is used to measure drug concentrations?

A

Blood

22
Q

What five things should bioanalytical methods be?

A

-Reproducible
-Selective
-Sensitive
-Precise
-Accurate

23
Q

The 90% Confidence Interval of the Relative Mean AUC vs. Time profile should fall within what range of values?

A

80 - 125%

24
Q

The 90% Confidence Interval of the Relative Mean Cmax values for Test Product (in comparison to the Reference Product) should fall within what range of values?

A

80 - 125%

25
Q

When conducting systemic effect analysis, the study should be performed under ______ (Fed / Fasted) conditions.

A

Fasted

26
Q

Bioequivalence for a MR dosage form must be demonstrated under which condition(s)?

Fed
Fasted
Both
Neither

A

Both

27
Q

Why must bioequivalency be demonstrated in both fed and fasting states for a Modified Release (MR) dosage form?

A

Increased risk of adverse effects (such as GI Irritation) & increased likelihood of Inter-Subject Variability in F values!

28
Q

The relative mean Cmin values for Test Products (vs. Reference Products) at steady state concentrations cannot be < ____%.

A

80%

29
Q

The 90% Confidence Interval of the Relative Mean AUC vs. Time profile for a Narrow TI drug must fall within what range of values?

A

90 - 112%

30
Q

The relative mean Cmax for a Narrow TI drug must fall between what range of values?

A

80 - 125%

31
Q

What drugs would be considered “Critical Dose Drugs” in bioequivalency studies?

A

-Cyclosporine
-Digoxin
-Flecainide
-Lithium
-Phenytoin
-Sirolimus
-Tacrolimus
-Theophylline
-Warfarin

32
Q

I’m conducting bioequivalency studies on Levothyroxine, a T4 hormone analogue… Briefly describe how I would determine exogenous drug levels.

A

-Obtain baseline levels of T4 from patient before administering drug, then gather total T4 levels at steady state & subtract those concentrations from baseline readings (to get just the exogenous drug concentrations).

33
Q

Only Class __ & __ BCS drugs qualify for biowaivers (& can thus be exempt from bioequivalency studies).

A

Class I & III

34
Q

Provided a drug falls within Class __ (ie. High Solubility & Permeability), it may qualify for a biowaiver in spite of existing as a different salt form than its Reference Product.

A

Class I

35
Q

I have a category Class III drug (Rizatriptan 10mg ODT) that I want to get patented. Would it qualify for biowaiver status (& thus bioequivalency exemption status)?

A

NOOOOO… Biowaivers only applicable to IR, Oral dosage forms (ODTs would not qualify)!

36
Q

What is the pH range for determining drug solubility?

A

1.2 - 6.8

37
Q

When determining a Test Product’s solubility status, how many samples along the pH range must be taken?

A

Three or more!

38
Q

Which of the following measured drug solubilities is used to classify a Test Product’s solubility status?

Highest
Intermediate
Lowest
All of the Above

A

Lowest

39
Q

What classifies a Test Product as having “high permeability”?

A

-85% (or greater) Absolute Bioavailability

-85% (or greater) of the administered dose appears unchanged in the urine

40
Q

What two categories of excipients can alter a Test Product’s extent &/or rate of absorption?

A

1) Sugar Alcohols (ie. Mannitol, Sorbitol)

2) Surfactants (ie. Sodium Lauryl Sulfate)

41
Q

I have a drug that is considered to be Class I. We want to determine (based upon inclusion excipient status) if it’s eligible for biowaiver status.

Test Prod: 65g Mannitol
Reference Prod: 75g Mannitol

Is it eligible for a biowaiver?

A

65g / 75g x 100% = 86.67%

100 - 86.67 = 13.33%

-Test product is no good for biowaiver status! Not within +/- 10%!!!

42
Q

I have a drug that is considered to be Class III. We want to determine (based upon inclusion excipient status) if it’s eligible for biowaiver status.

Test Prod: 65g Mannitol, 10g Sodium Lauryl Sulfate

Reference Prod: 65g Sorbitol, 10g Sodium Lauryl Sulfate

Is it eligible for biowaiver status?

A

NOOOOO!!! Although total masses of excipients are the exact same, we need them to be qualitatively (& quantitatively) the EXACT SAME (Mannitol is a different Sugar Alcohol than Sorbitol, so need to do bioequivalency studies).